Boston Scientific Corp. has received U.S. Food and Drug Administration (FDA) approval for the Watchman left atrial appendage closure device. The Watchman device offers a new stroke risk reduction option for high-risk patients with non-valvular atrial fibrillation who are seeking an alternative to long-term warfarin therapy.

Toshiba America Medical Systems Inc.’s Infinix 4DCT provides clinicians with faster, safer and more accurate interventions. Combining interventional radiology (IR) and computed tomography (CT), healthcare providers can plan, treat and verify in a single clinical setting for better patient care – rather than transferring patients between departments, risking infection and dragging out procedure times.

Precision Image Analysis (PIA) will be showcasing their remote post-processing solution for cardiac magnetic resonance (CMR) and cardiac computed tomography (CT) at the 2015 American College of Cardiology scientific session.

AtriCure Inc. announced the first two patients in the Dual Epicardial and Endocardial Procedure (DEEP) clinical study have been enrolled and treated at PinnacleHealth CardioVascular Institute in Harrisburg, Pennsylvania. The study is the first of its kind in the United States for the treatment of persistent or longstanding persistent forms of atrial fibrillation (Afib).

Researchers at the University of North Carolina (UNC) School of Medicine have found the blood platelet protein Rasa3 is critical to the success of the common anti-platelet drug Plavix. Plavix breaks up blood clots during heart attacks and other arterial diseases.

Infraredx announced it will premiere the Advanced TVC Imaging System and the Muller NIRS-IVUS Catheter featuring Extended Bandwidth IVUS technology at the American College of Cardiology’s 2015 Annual Scientific Meeting in San Diego, March 14-16.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now